Inventor
WANG ZHULUN
US24 patents
⚠️ This page may combine multiple inventors who share the name “WANG ZHULUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
22 patentsUS7132438B2Nov 7, 2006
Benzimidazole derivatives
AMGEN INC62 citations94
US9382318B2Jul 5, 2016
ST2 antigen binding proteins
AMGEN INC10 citations92
US9862752B2Jan 9, 2018
Growth differentiation factor 15 (GDF-15) constructs
AMGEN INC16 citations91
US9714276B2Jul 25, 2017
Growth differentiation factor 15 (GDF-15) polypeptides
AMGEN INC17 citations91
US10336798B2Jul 2, 2019
Growth differentiation factor 15 (GDF-15) polypeptides
AMGEN INC9 citations83
US9982054B2May 29, 2018
ST2 antigen binding proteins
AMGEN INC4 citations83
US11541103B2Jan 3, 2023
Interleukin-21 mutein/ anti-PD-1 antibody conjugates
AMGEN INC7 citations82
US11046774B2Jun 29, 2021
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
AMGEN INC5 citations81
US10465009B2Nov 5, 2019
BCMA antigen binding proteins
AMGEN INC9 citations81
US10294303B2May 21, 2019
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
AMGEN INC12 citations81
US11739131B2Aug 29, 2023
Growth differentiation factor 15 (GDF-15) polypeptides
AMGEN INC1 citations72
US11059895B2Jul 13, 2021
ST2 antigen binding proteins
AMGEN INC2 citations72
US12252540B2Mar 18, 2025
Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)
AMGEN INC1 citations71
US11891435B2Feb 6, 2024
Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof
AMGEN INC1 citations71
US11248043B2Feb 15, 2022
Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof
AMGEN INC1 citations71
US10894814B2Jan 19, 2021
Growth differentiation factor 15 (GDF-15) constructs
AMGEN INC4 citations71
US10738110B2Aug 11, 2020
PAC1 antibodies and uses thereof
AMGEN INC3 citations71
US11518808B2Dec 6, 2022
Anti-PD-1 antibodies and methods of treatment
AMGEN INC5 citations68
US11965029B2Apr 23, 2024
ST2 antigen binding proteins
AMGEN INC0 citations62
US7635774B2Dec 22, 2009
Benzimidazole derivatives
AMGEN INC3 citations60
US12435149B2Oct 7, 2025
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
AMGEN INC0 citations58
US10227414B2Mar 12, 2019
ST2 antigen binding proteins
AMGEN INC0 citations51